Immediate Suspension Order Issued for California Pharmaceutical Supplier
OCT 17 - (LOS ANGELES) – On October 15, 2008, Timothy J. Landrum, Special Agent in Charge of the Los Angeles Field Division, Drug Enforcement Administration (DEA) announced the Immediate Suspension of the DEA Certificates of Registration of Spectrum Laboratory Products, Inc.
Spectrum Laboratory Products, Inc., 14422 South San Pedro Street, Gardena, California, has been the subject of a DEA investigation alleging that the company was supplying large quantities of controlled substances to pharmacies engaged in selling these controlled substances based on prescriptions that were issued for other than legitimate medical purposes.
Timothy J. Landrum stated, “Spectrum Laboratory Products, Inc. has a responsibility to ensure that the drugs they sell are used for legitimate medical reasons. Non-medical use of addictive prescription drugs continues to increase throughout the United States at alarming rates. The diversion and abuse of controlled pharmaceuticals is one of the top priorities for the DEA. This action is an important step toward ensuring accountability of those who are supplying these drugs.”
The action today was to suspend Spectrum Laboratory Products, Inc.’s DEA Certificates of Registration in accordance with an Immediate Suspension Order and pursuant to Sections 303 and 304 of the Controlled Substances Act (CSA), Title 21, Sections 823 and 824. The DEA’s investigation of Spectrum Laboratory Products, Inc. has determined that the continued registration of this company constitutes an imminent danger to public health and safety. The Immediate Suspension Order is for Spectrum Laboratory Products, Inc.’s controlled substance registrations and not their chemical registrations.
Spectrum Laboratory Products, Inc. received written notice of the factual and legal basis for this action. In addition, Spectrum Laboratory Products, Inc. will be given an opportunity for an administrative hearing, and after the hearing, the DEA Deputy Administrator will make a final decision on whether Spectrum Laboratory Products, Inc.’s DEA Certificates of Registration should be permanently revoked. This decision will be published in the Federal Register.